Immix Biopharma - KOL event: Glimmer of hope for ALA patients
⬆ $Immix Biopharma Inc(IMMX)$ - Immix hosted a key opinion leader (KOL) event highlighting the long-term potential for NXC-201, the company’s B-cell maturation antigen (BCMA)...
Continue reading on Smartkarma:- https://www.smartkarma.com/insights/immix-biopharma-kol-event-glimmer-of-hope-for-ala-patients?utm_source=tiger_community
By Edison Investment Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/edison-investment-research?utm_source=tiger_community
On Immix Biopharma Inc (IMMX):- https://www.smartkarma.com/entities/immix-biopharma-inc?utm_source=tiger_community
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
